U.S. equities advanced on Wednesday, led by gains in technology and media stocks. The Dow Jones Industrial Average climbed approximately 250 points, reflecting broad market optimism driven by better-than-expected corporate earnings and analyst upgrades.

Technology Sector Leads Gains

Dell Technologies Inc (NYSE: DELL) shares rose 11.7% to $474.45. The rally followed the company’s report of second-quarter financial results that exceeded expectations, alongside third-quarter guidance above estimates.

Gitlab Inc (NASDAQ: GTLB) surged 14% to $51.41. Similar to Dell, Gitlab posted second-quarter results and guidance that surpassed analyst estimates.

Yext Inc (NYSE: YEXT) also benefited from positive earnings momentum, rising 10.8% to $7.24 after reporting better-than-expected second-quarter earnings.

Media and Healthcare Movers

Sirius XM Holdings Inc (NASDAQ: SIRI) jumped 5.5% to $29.12. Deutsche Bank upgraded the stock from Hold to Buy and raised its price target from $31 to $45.

In healthcare, First Tracks Biotherapeutics Inc (NASDAQ: TRAX) led the sector with a 16.5% gain to $47.98. Other notable risers included:

• OmniAb Inc (NASDAQ: OABI): +11.7% to $4.96
• Nanobiotix SA – ADR (NASDAQ: NBTX): +10.4% to $43.38
• Eupraxia Pharmaceuticals Inc (NASDAQ: EPRX): +10.3% to $6.99
• Zai Lab Ltd – ADR (NASDAQ: ZLAB): +7.9% to $27.28
• Scribe Therapeutics Inc (NASDAQ: SCTX): +7.5% to $31.18
• MiniMed Group Inc (NASDAQ: MMED): +7.5% to $24.10, following better-than-expected quarterly sales results.
• Telix Pharmaceuticals (NASDAQ: TLX): +7.4% to $11.65, after HC Wainwright & Co. analyst Robert Burns reiterated a Buy rating with a $20 price target.
• AtriCure Inc (NASDAQ: ATRC): +5.9% to $51.80, as Needham analyst Mike Matson raised the price target from $45 to $64.

Other Notable Movers

Alumis Inc (NASDAQ: ALMS) rose 10.7% to $10.48. HC Wainwright & Co. analyst Mitchell S. Kapoor upgraded the stock from Neutral to Buy but cut the price target from $25 to $15.

Corvex Inc (NASDAQ: MOVE) shares jumped 11.7% to $14.30.

AST SpaceMobile Inc (NASDAQ: ASTS) gained 8.4% to $60.46.

Sunshine Silver Mining & Refining Co (NYSE: SSMR) rose 8.4% to $18.20.

Sibanye Stillwater Ltd (NYSE: SBSW) climbed 7.5% to $12.53. The company reported a financial rebound for the first half of 2026, with adjusted EBITDA reaching nearly $2 billion.

Wingstop Inc (NASDAQ: WING) surged 6.4% to $116.56.

Ollie’s Bargain Outlet Holdings Inc (NASDAQ: OLLI) rose 6.3% to $76.88 after posting second-quarter results.

Telephone and Data Systems Inc (NYSE: TDS) gained 5.6% to $35.52. The company announced it is no longer pursuing the acquisition of public shares of Array Digital Infrastructure.

What the Numbers Show

The market’s upward movement was concentrated in companies delivering operational beats or receiving positive analyst revisions. Dell and Gitlab demonstrated that exceeding consensus estimates for both current results and forward guidance can drive significant single-day returns, with gains exceeding 10%. Conversely, Alumis saw its stock rise despite a price target cut, suggesting the upgrade from Neutral to Buy was the primary driver for investors, outweighing the lower valuation ceiling.

U.S. equity markets traded higher on Wednesday, led by a significant rally in the Dow Jones Industrial Average. The index gained more than 200 points, closing at 52,986.22, a rise of 0.42%. Broader indices also posted gains, with the S&P 500 up 0.11% to 7,639.90 and the NASDAQ Composite edging up 0.01% to 26,100.26.

Sector Performance and Market Movers

Materials stocks emerged as the top-performing sector, jumping 1.5% during the session. In contrast, real estate shares lagged, falling 1.2%.

Individual stock movements were driven by earnings reports and corporate announcements. Ollie's Bargain Outlet Holdings Inc (NASDAQ: OLLI) shares gained around 5% after reporting second-quarter results. The company posted an adjusted earnings per share (EPS) of $1.42, beating market estimates of $1.14. However, sales of $741.305 million missed expectations of $752.852 million.

Other notable gainers included:

• Linkhome Holdings Inc (NASDAQ: LHAI), which shot up 44% to $1.18 after its subsidiary, Linkhome Technologies, initiated a preliminary evaluation of an AI computing infrastructure project in Europe involving up to 144 NVIDIA GB300 GPUs.
• Purple Biotech Ltd – ADR (NASDAQ: PPBT), surging 36% to $2.26 following a U.S. PTO Notice of Allowance for a patent on tri-specific antibody constructs.
• bioAffinity Technologies Inc (NASDAQ: BIAF), gaining 45% to $9.55 on plans to advance its CyPath Lung test application.

Conversely, several equities faced sharp declines:

• Tscan Therapeutics Inc (NASDAQ: TCRX) dropped 26% to $0.49 after pausing enrollment in its Phase 3 ALLOHA-2 study due to insufficient capital and announcing a 75% workforce reduction.
• CDT Equity Inc (NASDAQ: CDT) fell 22% to $1.15 following disclosures of share issuance, Nasdaq listing status changes, and executive leadership shifts.
• Alpha Modus Holdings Inc (NASDAQ: AMOD) declined 21% to $2.20.

Global Markets and Commodities

European markets closed mostly lower. The STOXX 600 slipped 0.4%, while Germany’s DAX and London’s FTSE 100 both dipped 0.4%. France’s CAC 40 fell 0.1%, though Spain’s IBEX 35 rose 0.1%.

Asian markets also closed lower, with Japan’s Nikkei 225 falling 2.85% and China’s Shanghai Composite declining 0.97%. Hong Kong’s Hang Seng index declined 0.07%, and India’s BSE Sensex fell 0.02%.

In commodities, oil prices traded down 0.4% to $89.85, while gold fell 0.4% to $4,378.90. Silver dropped 0.8% to $64.845, but copper rose 0.1% to $6.6095.

Economic Data

U.S. private businesses added 38,000 jobs in August, down from a revised 46,000 gain in July and below market estimates of 47,000. Meanwhile, mortgage application volumes rose by 0.8% during the last week of August.

What the Numbers Show

Ollie's Bargain Outlet demonstrates a divergence between profitability and top-line growth. While the company beat EPS estimates by $0.28 per share, it missed revenue expectations by approximately $11.5 million. This suggests that cost management or non-operational factors drove the earnings beat, rather than robust sales performance, which fell short of consensus forecasts.